How many institutions held IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share in Q1 2018?

34 institutional investors reported IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share for Q1 2018. Use the holders table for investor-level position and value details.

IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD)

Q: What does CUSIP 46266A109 represent in this 13F holders report?

CUSIP 46266A109 is the security identifier for IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 46266A109

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 12,788,649
Total 13F shares: 1,710,580
Share change: +185,430
Total reported value: $24,258,264
Price per share: $14.13
Number of holders: 34
Value change: +$2,579,198
Number of buys: 14
Number of sells: 13

Quarterly Holders Quick Answers

What is CUSIP 46266A109?
CUSIP 46266A109 identifies IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 46266A109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IRMD - IRADIMED CORP - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
AMERIPRISE FINANCIAL INC	13F	Company	3.7%	467,982	$7,090,000	—	31 Dec 2017	13F
Mondrian Investment Partners LTD	13F	Company	1.6%	206,547	$3,129,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	1.4%	185,215	$2,806,000	—	31 Dec 2017	13F
Granite Investment Partners, LLC	13F	Company	0.78%	99,238	$1,503,000	—	31 Dec 2017	13F
MENTA CAPITAL LLC	13F	Company	0.52%	66,976	$1,015,000	—	31 Dec 2017	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.49%	62,294	$944,000	—	31 Dec 2017	13F
Eversept Partners, LP	13F	Company	0.4%	51,059	$773,544	—	31 Dec 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.37%	47,770	$724,000	—	31 Dec 2017	13F
Boston Partners	13F	Company	0.35%	44,321	$671,000	—	31 Dec 2017	13F
BlackRock Finance, Inc.	13F	Company	0.34%	43,224	$655,000	—	31 Dec 2017	13F
FEDERATED HERMES, INC.	13F	Company	0.31%	39,989	$606,000	—	31 Dec 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.27%	35,021	$548,000	—	31 Dec 2017	13F
Spark Investment Management LLC	13F	Company	0.27%	34,203	$518,000	—	31 Dec 2017	13F
CONNORS INVESTOR SERVICES INC	13F	Company	0.26%	33,000	$500,000	—	31 Dec 2017	13F
Informed Momentum Co LLC	13F	Company	0.24%	30,141	$457,000	—	31 Dec 2017	13F
Unison Advisors LLC	13F	Company	0.23%	29,250	$443,000	—	31 Dec 2017	13F
Stone Ridge Asset Management LLC	13F	Company	0.2%	26,141	$396,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.2%	25,310	$383,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.19%	23,936	$362,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.18%	23,100	$349,000	—	31 Dec 2017	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.17%	21,210	$323,000	—	31 Dec 2017	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.16%	21,098	$320,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	0.16%	20,941	$318,000	—	31 Dec 2017	13F
Neuberger Berman Group LLC	13F	Company	0.16%	20,500	$311,000	—	31 Dec 2017	13F
Ranger Investment Management, L.P.	13F	Company	0.12%	15,697	$238,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	0.12%	15,432	$234,000	—	31 Dec 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.09%	10,885	$165,000	—	31 Dec 2017	13F
MACQUARIE GROUP LTD	13F	Company	0.06%	8,204	$124,000	—	31 Dec 2017	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	7,444	$113,000	—	31 Dec 2017	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.05%	6,500	$98,000	—	31 Dec 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.03%	4,234	$64,000	—	31 Dec 2017	13F
UBS Group AG	13F	Company	0.01%	1,741	$26,000	—	31 Dec 2017	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	1,622	$25,000	—	31 Dec 2017	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,073	$17,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	500	$8,000	—	31 Dec 2017	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1	$15	—	31 Dec 2017	13F

Institutional Holders of IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD) as of Q1 2018

As of 31 Mar 2018, IRADIMED CORP - Common Stock, par value $0.0001 per share (IRMD) was held by 34 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,710,580 shares. The largest 10 holders included AMERIPRISE FINANCIAL INC, VANGUARD GROUP INC, Ranger Investment Management, L.P., CADENCE CAPITAL MANAGEMENT LLC, Boston Partners, Menta Capital LLC, Russell Investments Group, Ltd., ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, and Eversept Partners, LP. This page lists 34 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

Q1 2018 holders

Holder diff

-2

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.